Minoxidil Topical Solution USP, 5%

Saw Palmetto vs. Finasteride: Comparing the Natural Option to the Drug

Saw palmetto and finasteride both get described as "DHT blockers," but they are not two versions of the same idea. Finasteride is an FDA-approved prescription drug that suppresses serum DHT by roughly two-thirds within a day of a single dose, tested in trials with thousands of men over years. Saw palmetto is a plant extract that has inhibited the same enzyme in laboratory dishes, with a much smaller and more mixed body of human evidence behind it, and a shampoo built around it only gets a couple of minutes of scalp contact per wash. Comparing them fairly means separating what each one's evidence actually supports from what a product page or a forum thread implies.

  • Different strength, not just different form. Finasteride selectively and consistently blocks the Type II enzyme responsible for most scalp DHT; saw palmetto's inhibition is non-selective and varies widely between commercial extract brands and batches.
  • The one head-to-head trial favoured finasteride clearly. Over two years, 68% of men on finasteride showed improved growth versus 38% on saw palmetto, with finasteride reaching more advanced loss and more of the scalp.
  • Saw palmetto's own evidence is real but thin. A systematic review found promising results, mostly from combination supplements rather than saw palmetto alone, and called the evidence base not yet robust.
  • Finasteride carries risks that need a doctor's judgment, including sexual side effects that occur more often than on placebo and, rarely, ones reported to persist after stopping. This brand does not sell or dose it.

How Saw Palmetto and Finasteride Are Supposed to Work

Pattern hair loss is driven largely by dihydrotestosterone, or DHT, gradually shrinking genetically susceptible follicles until they stop producing visible hair. Both products are marketed around reducing DHT's effect on the scalp, but "reducing DHT" covers a wide range of actual potency, and that range is where the two options separate. For a fuller walk-through of how 5-alpha-reductase inhibition works and what a DHT blocker actually blocks, see this explainer on what a DHT blocker is and how it works; if you are not yet sure your own hair loss is the pattern type these products target, this overview of androgenetic alopecia covers how it is recognised.

Finasteride is a competitive, specific inhibitor of the Type II 5-alpha-reductase isozyme, the form most responsible for converting testosterone to DHT in the scalp and hair follicles. In laboratory binding studies it showed roughly 100-fold selectivity for Type II over Type I, and a single 1 mg oral dose suppresses serum DHT by about 65% within 24 hours (source: PROPECIA prescribing information, DailyMed). That is a targeted, measured, reproducible effect, which is a large part of why it earned drug approval in the first place.

Saw palmetto works through a different route. Its fatty acids and phytosterols have inhibited 5-alpha-reductase in laboratory assays, but testing across seven different commercial Serenoa repens extract brands found the inhibition was non-selective, hitting both Type I and Type II unevenly, and that potency varied a great deal between brands and even between batches of the same brand (source: Scaglione et al., Pharmacology, 2008). A supplement or a shampoo that lists saw palmetto is not delivering a standardised dose the way a regulated tablet does, which is one reason "blocks DHT" means something narrower and more provable on a drug label than it does on a product page.

What the Studies Actually Show

Mechanism explains why a difference is plausible; the actual research is what tells you how large it is. Two separate bodies of evidence matter here: a direct head-to-head trial between the two options, and each option's own independent evidence base.

The one study that compared them directly

A two-year randomised trial followed 100 men with mild-to-moderate androgenetic alopecia, splitting them between finasteride 1 mg/day and saw palmetto 320 mg/day. By the end of the study, 68% of the finasteride group showed improved hair growth compared with 38% of the saw palmetto group. The gap widened further in more advanced loss: finasteride worked noticeably better in stage II-III alopecia and improved growth across both the front and the vertex of the scalp, while saw palmetto's benefit was concentrated mainly at the vertex (source: Rossi et al., International Journal of Immunopathology and Pharmacology, 2012). This is the only trial that has put the two substances against each other directly, so it carries real weight, but it is a single study of modest size and should be read alongside each option's larger evidence base rather than as the final word on its own.

What finasteride's own trials found

Finasteride's pivotal placebo-controlled trials give a longer, larger picture. At 12 months, 58% of men on placebo showed further hair loss compared with 14% on finasteride, and the hair-count advantage over placebo continued to widen through five years of continued treatment (source: PROPECIA prescribing information, DailyMed). That durability is one reason it is indicated specifically for men; a separate 12-month placebo-controlled study in 137 postmenopausal women found no improvement over placebo in hair count or in patient and investigator assessments, which is why the label does not extend to women. The gains are also not permanent on their own terms: stopping the drug tends to reverse the improvement within about a year, so its label describes ongoing use rather than a one-time course.

Saw palmetto's own evidence base is smaller and more scattered. A systematic review covering five randomised trials and two cohort studies found real improvements in some measures, including roughly 27% average gains in hair count in certain studies, but the reviewers were candid that most of the tested products combined saw palmetto with other ingredients rather than isolating its contribution, at doses ranging from 100 to 320 mg, and they described the overall evidence as promising rather than robust (source: Evron et al., Skin Appendage Disorders, 2020). None of that research tested a rinse-off shampoo specifically; the oral and leave-on studies are the closest available evidence, and a wash that spends two or three minutes on the scalp before rinsing sits further still from what was actually measured. Calling saw palmetto a "natural alternative to finasteride" overstates what this research currently supports; it is a genuinely studied ingredient with a real but modest and inconsistent track record, not a lower-strength stand-in for a drug with a much larger and more selective effect.

Side Effects and Who Shouldn't Use Either One

The two options also carry very different risk profiles, and that difference is as important to the decision as effectiveness. In finasteride's three 12-month placebo-controlled trials, covering 945 men on the drug and 934 on placebo, drug-related effects included decreased libido (1.8% versus 1.3% on placebo), erectile dysfunction (1.3% versus 0.7%) and ejaculation disorder (1.2% versus 0.7%), and most of these resolved after stopping treatment. Postmarketing reports also describe sexual dysfunction that persisted after discontinuation in some men, along with reports of depression and suicidal ideation (source: PROPECIA prescribing information, DailyMed). Finasteride is also contraindicated in pregnancy, because inhibiting 5-alpha-reductase can interfere with normal genital development in a male fetus, and it is not indicated for women or for anyone under 18.

Saw palmetto's tolerability record in the reviewed studies was good, with no serious adverse events reported. That is a genuine point in its favour for someone who is risk-averse, but a clean safety record in small studies is not the same claim as matching finasteride's demonstrated effect, and the two shouldn't be weighed as if they were interchangeable on that basis alone. This brand does not sell or dose finasteride, and nothing here is meant to tell you to start or stop it: that decision, including whether the side-effect profile is acceptable for your own health history, belongs with a doctor who can review it properly. This guide on when it makes sense to see a dermatologist walks through what that conversation usually covers.

Deciding What to Try First

If the goal is the strongest evidence available without a prescription, minoxidil is the more directly comparable option to weigh against finasteride, not saw palmetto. It is the only active in this range with an approved regrowth indication, and its own trial evidence, while different in scope from finasteride's, is far more extensive than saw palmetto's. Its approved use is specifically the vertex of the scalp; this piece on minoxidil and a receding hairline covers why that label boundary matters if your loss is more at the front.

Minoxidil Topical Solution USP, 5%, the range's only active with an approved hair-regrowth indication
Minoxidil Topical Solution USP, 5% is the more evidence-comparable non-prescription option to weigh against finasteride.

Saw palmetto still has a place, just a more modest one. As a scalp-comfort addition alongside a regimen, or as a lower-commitment starting point for someone who isn't ready for a prescription conversation yet, it is a reasonable thing to try. The Saw Palmetto DHT Shampoo pairs saw palmetto fruit extract with 1% niacinamide, which supports the skin barrier and eases redness and irritation, and 0.2% caffeine, at the concentration used in published leave-on research, though a rinse-off wash gives it only a couple of minutes of contact time. The product page is direct about this: the clinical evidence behind saw palmetto is limited and mostly comes from oral studies rather than a shampoo, and nobody should read "DHT" on the label as finasteride in another format.

Saw Palmetto DHT Shampoo with niacinamide and caffeine
Saw Palmetto DHT Shampoo fits as a scalp-comfort step alongside a regimen, not as a finasteride substitute.

A practical way to sort the choice is to ask how established the evidence needs to be before you're comfortable using something, how much risk you're willing to accept for a larger potential effect, and how you feel about having a prescription conversation with a doctor in the first place. Someone who wants the best-studied non-prescription option can start with minoxidil; someone who wants a lower-risk addition to a wider routine, or isn't ready to consider a prescription yet, can reasonably choose the saw palmetto shampoo. Someone who wants the effect size finasteride's own trials showed will need that conversation with a doctor, because this is a decision the evidence alone cannot make for you.

Back to blog